Cupid secures CE (EU IVDR) Certification for two in-vitro diagnostic products

29 Jan 2026 Evaluate

Cupid has secured CE (EU IVDR) Certification for two in-vitro diagnostic (IVD) products -- the CupiKIT HIV 1&2 Antibody Test Kit and the CupiKIT Hepatitis B Surface Antigen (HBsAg) Test Kit. These approvals enable the company to market the certified products across the European Economic Area (EEA) and other CE-recognized international markets. The certifications have been granted under the European Union In Vitro Diagnostic Regulation (EU) 2017/746 (IVDR), among the most stringent regulatory standards globally. 

The newly certified products are intended for early detection and large-scale screening programs, particularly across public health initiatives and institutional procurement channels in Europe, Africa, and other emerging markets. The certifications also enhance the company’s eligibility to participate in government tenders, multilateral agency programs, and regulated international healthcare supply chains where EU IVDR compliance is mandatory. These certifications further reinforce the company’s transition into a broader, innovation-led healthcare and diagnostics platform and positions it to capitalize on rising global demand for accurate, affordable, and rapid diagnostic solutions.

Cupid manufactures and markets varieties of male and female condoms, water-based lubricant, latex dental dams and probe covers. The company has a diverse product basket available in many countries worldwide.

Cupid Share Price

407.00 5.50 (1.37%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2351.15
Godrej Consumer Prod 1162.35
Dabur India 502.25
Colgate Palmol. (I) 2106.40
P&G Hygiene 11927.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×